ACE2 and diabetes mellitus: Another study by D’Onofrio et al. shows that the upregulation of ACE2 expression (both total and glycosylated forms) in diabetes mellitus cardiomyocytes, together with an increase in non-enzymatic glycation, may increase susceptibility to COVID-19 infection in diabetes mellitus patients by promoting cellular entry of SARS-CoV2 [32].